References
- Agency for Toxic Substances and Disease Registry. (ATSDR, 2005). Draft toxicological profile for lead, pp.102-225, US Department of health and human services, Atlanta, Georgia, USA.
- Agency for Toxic Substances and Disease Registry. (ATSDR, 2007). Case studies in Environmental Medicine Lead Toxicity, Course: WB 1105, August 20, Atlanta, Georgia, USA.
- Bergmeyer H and Bernt E. (1950). Practical Clinical Biochemistry (Varley H, Gowenlock AH, Bell M eds), 5th Edn, pp 741-812 William Heinmann Medical Books Ltd London.
- Bird RP and Draper HH. (1980). Effect of malonaldehyde and acetaldehyde on cultured mammalian cells: Growth, morphology, and synthesis of macromolecules. J Toxicol Environ Health 6(4): 811-823.
- Canalis E, Centrella M, Bunch W and McCarthy TL. (1989). Insulin like growth factor I mediates selective anabolic effects of PTH in bone cultures. J Clin Invest 83: 60-65.
- Devasagayam TD and Terachand U. (1987). Decreased lipid peroxidation in rat kidneys during gestation. J Biochem Biophys Res Commun 145: 134-138.
- Ercal N, Gurer-Orhan H and Aykin-Burns N. (2001). Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Review. Curr Top Med Chem 1(6): 529-539.
- Frodovich I. (1995). Superoxide radical and superoxide dismutase. Annu Rev Biochem 64: 97-112.
- Habig WH, Pabst MJ and Jackoby WB. (1973). The first enzymatic step in mercapturic formation. J Biol Chem 249: 7130-13 9.
- Hande, G and Naran E. (2000). Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic. Biol.Med 29(10), 927-945.
- Hayes JD and Pulford DJ. (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
- Inouye, Yoshio et al. (2001). Comparative Study on in vitro Inhibitory Effects of Heavy Metals on Rabbit Drug-Metabolizing Enzymes. Journal of Health Sciences 47: 14-20.
- Juberg, DR, Kleiman C F, Kwon, SC. (1997). Position paper of the American council on science and health: Lead and human health. Ecotoxicol. Environ. Saf 38, 162-180.
- Klein RF and Wiren KM. (1993). Regulation of osteoblastic gene expression by lead. Endocrinology 132(6): 2531-2537.
- Kono Y and Fridovich I. (1982). Superoxide radical inhibits catalase. J Biol Chem 257(10): 5751-5754.
- Kono Y. (1978). Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys 186: 189-195.
- Kowaltowski AJ, Vercesi AE, Rhee SG and Netto LE. (2000). Catalases and thioredoxin peroxidase protect Saxxharomyces cerevisiae against Ca2+ induced mitochondrial memebrane permeabilization and cell death. FEBS Lett 473: 177-182.
- Liu G, Men P, Kenner GH and Miller SC. (2008). Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats. Hemoglobin 32(1-2): 181-190.
- Lowry OH, Rosebrough NJ, Farr AL and Randall RJ. (1951). Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275.
- Luck H. (1971). In: Methods of enzymatic analysis. Ed: H.U. Bergmeyer, Academic Press, New York 885-893.
- Lyn P. (2006). Lead toxicity, a review of the literature. Part I: exposure, evaluation and treatment. Altern Med Rev 11: 2-22.
- Majeska RJ and Wurthier RE. (1975). Studies in matrix vesicles in epiphyseal cartilage I. In vivo incorporation of 32P orthophosphate into phospholipids of chondrocyte, membrane and matrix vesicle fraction. Biochem Biophys Acta 391: 51-60.
- Mody Nilam, Parhami Farhad A Sarafian Theodore and Linda L Demer. (2001). Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free radiacl biology and medicine 31(4): 509-519.
- Muller FL, Lustgarten MS, Jang Y, Richardson A, and Van Remmen H. (2007). Trends in oxidative aging theories. Free Radic. Biol.Med 43, 477-503.
- Plummer DT. (1988). In: Introduction to practical biochemistry. Third Edition, Copyright ©Tata Mac Graw Hill Company (UK) Limited 220-221.
- Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook MG and Ebert TS. (1987). Genetic determinants of bone mass in adults: A twin study. Journal of Clinical investigation 80: 706-710.
- Pounds JG, Long GJ, and Rosen JF. (1991). Cellular and molecular toxicity of lead in bone. Environ Health Perspect 19: 17-32.
- Sánchez-Rodríguez MA, Ruiz-Ramos M, Correa-Muñoz E and Mendoza-Núñez VM. (2007). Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 8: 124.
- Shen CL, Wang P, Guerrieri J, Yeh JK and Wang JS. (2008). Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 19(7): 979-990.
- Shih RA, Hu H, Weisskopf MG and Schwartz BS. (2007). Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Review. Environ Health Perspect 115(3): 483-492.
- Shoty K, Weiss DW, Appleby PG, Chebrkin AK, Gloor RFM, Kramens JD et al. (1998). History of atmosphearic lead deposition since 12,370. (14) C yr BP from a peat bog, jura mountains, Switzerland Science 281, 1635 - 1640.
- Smith DM Jr, Mielke HW and Heneghan JB. (2008). Subchronic Lead Feeding Study in Male Rats. Arch Environ Contam Toxicol [Epub ahead of print].
- Tada-Oikawa S, Oikawa S, Kawanishi M, Yamada M and Kawanishi S. (1999). Generation of hydrogen peroxide precedes loss of mitochondrial memebrane potential during DNA alkylationinduced apoptosis. FEBS Lett 442: 65-69.
- Turner RT and Spelsberg TC. (1991). Correlation between mRNA levels for bone cell proteins and bone formation in long bones of maturing rats. Am J Physiol 1(3 Pt 1): E348-53.